Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test
NCT ID: NCT00236171
Last Updated: 2010-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2004-09-30
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients
NCT02908347
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
NCT01871402
Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test
NCT02432027
Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis
NCT01245140
Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis
NCT01230138
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
TRIPLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Protopic, Advantan
Blood and Urine Test
coherence tomography
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Negative urine pregnancy test
* Written informed consent
* Good compliance
Exclusion Criteria
* Pregnant patients
* Patients with renal insufficiency, liver diseases
* Patients who received systemic antipsoriatic treatment or UV treatment less than 4 weeks prior to study
* Patients who used topical antipsoriatics within two weeks prior to study
* Immunosuppressed Patients
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Technische Universität Dresden
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Technical University Dresden
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gottfried Wozel, Professor
Role: PRINCIPAL_INVESTIGATOR
Technische Universität Dresden
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Technische Universität Dresden
Dresden, Saxony, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ETAPSO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.